Capreomycin

Capreomycin
Capreomycin
Systematic (IUPAC) name
(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide; (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a682860
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 11003-38-6 YesY
ATC code J04AB30
PubChem CID 3032400
DrugBank APRD00844
ChemSpider 21106276 YesY
UNII 232HYX66HC YesY
KEGG D00135 N
ChEMBL CHEMBL1201252 N
Chemical data
Formula C25H44N14O8 
Mol. mass 668.706 g/mol
 N(what is this?)  (verify)

Capreomycin is a peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.

The drug should not be given with streptomycin or other drugs that may damage the 8th nerve.

It is a cyclic peptide. Capreomycin is administered intramuscularly and shows bacteriostatic activity. [1]

References